Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Rajmohan Murali
Based on 78 articles published since 2008
||||
Expertise Level
The expertise of Rajmohan Murali ranks in the
  • Top 0.062%
  • ... of 107,286 published authors worldwide on Melanoma
  • ... from 2008 through 2019
  • ... based on contributions to 78 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Murali, Rajmohan   ·   Murali, R
Work Locations
Details
Most likely:    Memorial Sloan-Kettering Cancer Center   Contact    
2017
  • Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, The Netherlands. Electronic address: · Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, The Netherlands. Electronic address: · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, United States. Electronic address: · Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, The Netherlands. Electronic address: · Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, The Netherlands. Electronic address: · Department of Surgical Oncology, University of Leiden, Leiden University Medical Center, The Netherlands. Electronic address: · Pubmed 28797756
  • Department of Ophthalmology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany. · Institute of Pathology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany. · Department of Ophthalmology, University Hospital Tübingen, Tübingen, Germany. · Institute of Pathology, Ruhr University Bochum, Bochum, Germany. · Department of Dermatology, University Hospital Würzburg, Würzburg, Germany. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, United States. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany 8Dermatopathologie bei Mainz, Nieder-Olm, Germany. · Pubmed 28700778
  • Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany. · Dermatopathologie bei Mainz, Nieder-Olm, Germany. · Dermatopathology Friedrichshafen, Friedrichshafen, Germany. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · The University of Sydney, Camperdown, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Pathologie Salzburg, Salzburg, Austria. · Institute of Neuropathology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany. · Institute of Pathology, Ruhr University Bochum, Bochum, Germany. · Department of Dermatology, Medical University of Vienna, Vienna, Austria. · Department of Ophthalmology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany. · Department of Dermatology, University Hospital Würzburg, Würzburg, Germany. · Institute of Pathology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York NY, USA. · Pubmed 28409567
  • Institute of Pathology, Ruhr University Bochum, Bochum, Germany; Institute of Neuropathology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany. · Department of Neuropathology, Ruprecht-Karls-University Heidelberg, and Clinical Cooperation Unit Neuropathology, and DKTK, DKFZ, Heidelberg, Germany. · Institute of Neuropathology, University of Bonn Medical Center, Bonn, Germany; Division of Histopathology, Fondazione Policlinico Universitario "A.Gemelli", Università Cattolica del Sacro Cuore, Roma, Italy. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; The University of Sydney, Camperdown, NSW, Australia; Melanoma Institute Australia, North Sydney, NSW, Australia. · The University of Sydney, Camperdown, NSW, Australia; Department of Neuropathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Institute of Neuropathology, University of Bonn Medical Center, Bonn, Germany. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany; Dermatopathologie bei Mainz, Nieder-Olm, Germany. Electronic address: · Pubmed 28499758
2016
  • Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, United States; Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria. Electronic address: · Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria; Dermatopathologie Friedrichshafen, Friedrichshafen, Germany. · Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria. · Melanoma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, United States. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, United States; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, United States. · Pubmed 27020384
  • Institute of Neuropathology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Duisburg-Essen, Germany. · Institute of Neuropathology, University of Bonn Medical Center, Bonn, Germany. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) University of Duisburg-Essen, Duisburg-Essen, Germany. · Department of Ophthalmology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Duisburg-Essen, Germany. · Institute of Human Genetics, Medical University of Graz, Graz, Austria. · Tissue Pathology and Diagnostic Oncology, Camperdown, NSW, Australia. · The University of Sydney, Camperdown, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Department of Neuropathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Pathology, Catholic University, Rome, Italy. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) University of Duisburg-Essen, Duisburg-Essen, Germany. · Pubmed 26744134
  • Institute of Neuropathology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Germany. · Department of Neurosurgery, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Germany. · Department of Radiology and Neuroradiology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Germany. · Department of Translational Skin Cancer Research, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Germany. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Germany. · Department of Ophthalmology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Germany. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Institute of Neuropathology, University of Bonn Medical Center, Bonn, Germany. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Germany. Electronic address: · Pubmed 27060446
2015
  • Department of Pathology, University of California, San Francisco, San Francisco, California, USA. · Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Department of Dermatology, University of California, San Francisco, San Francisco, California, USA. · Five3 Genomics, LLC, Santa Cruz, California, USA. · Samsung Advanced Institute of Technology, Seoul, Korea. · Department of Biomedical Engineering, Oregon Health and Sciences University, Portland, Oregon, USA. · Knight Cancer Institute, Oregon Health and Sciences University, Portland, Oregon, USA. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA. · Samsung Electronics Headquarters, Seoul, Korea. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Pubmed 26343386
  • Department of Ophthalmology, University Hospital Essen, University Duisburg-Essen, West German Cancer Center and the German Cancer Consortium (DKTK), Essen Germany. · Department of Dermatology, University Hospital Essen, University Duisburg-Essen, West German Cancer Center and the German Cancer Consortium (DKTK), Essen Germany. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York NY, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York NY, USA. · University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen Germany. · Institute of Pathology, University Hospital Essen, University Duisburg-Essen, West German Cancer Center and the German Cancer Consortium (DKTK), Essen Germany. · Department of Human Genetics, University Hospital Essen, University Duisburg-Essen, West German Cancer Center and the German Cancer Consortium (DKTK), Essen Germany. · Pubmed 26327518
  • NantOmics LLC, Santa Cruz, CA 95060; · Samsung Advanced Institute of Technology, Suwon-si, Gyeonggi-do, 443-803, Korea; · Department of Statistics, University of California, Berkeley, CA 94720-3860; · Department of Biomedical Engineering, Knight Cancer Institute, Oregon Health Sciences University, Portland, OR 97239; · Melanoma Institute Australia, Crows Nest, NSW 1585, Australia; · Department of Medical and Molecular Genetics, Oregon Health & Science University, Portland, OR 97239-30; · Melanoma Institute Australia, Crows Nest, NSW 1585, Australia; Royal Prince Alfred Hospital, The University of Sydney, Camperdown, NSW 2050, Australia; · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095; · Department of Hematology and Oncology, University of California, San Francisco, CA 94143-1770; · Samsung Electronics, Inc. Seocho-gu, Seoul 137-857, Korea; · Department of Dermatology, University of California, San Francisco, CA 94115; · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Pathology, University of California, San Francisco, CA 94143-0511 · Pubmed 26286987
  • Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) (KGG, DS) · Department of Pathology (RM) and Marie-Josée and Henry R. Kravis Center for Molecular Oncology (RM), Memorial Sloan Kettering Cancer Center, New York, NY · Integriertes Forschungs- und Behandlungszentrum (IFB) Sepsis und Sepsisfolgen, Center for Sepsis Control and Care (CSCC) University Hospital Jena, Jena Germany (AS). · Pubmed 25755156
2014
  • Affiliations of authors: Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany (KGG, DS) · Royal Prince Alfred Hospital, Camperdown, NSW, Australia (RAS) · University of Sydney, Camperdown, NSW, Australia (RAS, JFT) · Melanoma Institute Australia, North Sydney, NSW, Australia (RAS, JFT) · Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA (KTF) · Department of Pathology, and Center for Molecular Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY (RM). · Pubmed 24511108
  • Department of Dermatology,University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen and the German Cancer Consortium (KGG, BS, EL, TS, IM, MS, AS, UH, LZ, DS), Germany · Department of Pathology and Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY (RM) · CIBER Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain (JAPB, MP, CC, CB, JM, SP) · Department of Dermatology, Hospital Clinic Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain (CC, JM, SP) · Biochemistry and Molecular Genetics Department, Hospital Clinic Barcelona, IDIBAPS, Barcelona, Spain (CB) · Integriertes Forschungs- und Behandlungszentrum (IFB) Sepsis und Sepsisfolgen Center for Sepsis Control and Care (CSCC) University Hospital Jena, Jena, Germany (AS). · Pubmed 25217772
  • Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California (D.M.M., J.L.H., D.S.B.H.) · Department of Tissue Oncology and Diagnostic Pathology (R.A.S., M.E.B., J.F.T.) and Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia (J.F.T.) · Sydney Medical School, The University of Sydney, Sydney, Australia (R.A.S., J.S.W., M.E.B., J.F.T.) · Melanoma Institute Australia, Sydney, Australia (R.A.S., J.S.W.) · Cellular and Molecular Biology Laboratory, Institute of Histology and Embryology, Mendoza, Argentina (M.R.) · Tumor Biology Laboratory, Institute of Medicine and Experimental Biology of Cuyo, Mendoza, Argentina (L.M.V.-R.) · Department of Pathology (R.M.), Center for Molecular Oncology (R.M.), and Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York (R.M.) · Division of Surgical Oncology, John Wayne Cancer Institute, Santa Monica, California (D.L.M.) · Brain Tumor Center, Saint John's Health Center, Santa Monica, California (G.B., D.F.K.). · Pubmed 24968695
  • Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, 415 E 68th Street, New York, New York 10065, USA. · Department of Dermatology and Venereology, Medical University of Graz, Auenbruggerplatz 8, 8036 Graz, Austria. · Foundation Medicine, 1 Kendall Sq B6501, Cambridge, Massachusetts 02139, USA. · Departments of Dermatology and Pathology, UCSF Cardiovascular Research Institute, 555 Mission Bay Blvd. South, Room 252K, Box 3118, San Francisco, California 94158-9001, USA. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue New York, New York 10065, USA. · Dermatopathologie Friedrichshafen, Siemensstraße 6/1, 88048 Friedrichshafen, Germany. · Pubmed 24445538
  • Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. · Melanoma Institute Australia, Sydney, Australia. · Memorial Sloan Kettering Cancer Center, New York City, NY, USA. · Institut de Cancerologie Gustav Roussy, Villejuif, Paris-Sud, France. Electronic address: · Pubmed 24074765
  • Department of Dermatology, University of Duisburg-Essen, Essen, Germany. · Institute of Pathology and Neuropathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. · 1] The University of Sydney, Camperdown, NSW, Australia [2] Melanoma Institute Australia, North Sydney, NSW, Australia. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] The University of Sydney, Camperdown, NSW, Australia [2] Melanoma Institute Australia, North Sydney, NSW, Australia [3] Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · 1] Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA [2] Department of Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 23887304
2013
  • Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 23277170
  • Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. Electronic address: · Pubmed 23890716
2012
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 22350600
  • Melanoma Institute Australia, Sydney, New South Wales, Australia. · Pubmed 22736239
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, and Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 22271204
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 21975320
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 21913010
2011
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 21438911
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 21412144
2013
  • *Department of Pathology, University of Virginia School of Medicine, Charlottesville VA †Department of Pathology ‡Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, United States. · Pubmed 24247622
  • *Department of Pathology †Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, USA ‡Melanoma Institute Australia, North Sydney §Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown ||Disciplines of Pathology ¶Surgery, Sydney Medical School, The University of Sydney, Camperdown NSW, Australia. · Pubmed 24018818
2012
  • Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Box 20, New York, NY 10065, USA. · Pubmed 23032617
2009
  • Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 19609204
Probable:    Royal Prince Alfred Hospital      
2012
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 22350600
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, and Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 22271204
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 21975320
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 21913010
2011
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 21438911
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 21412144
2010
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 20106719
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 20823419
  • Diagnostic Oncology and Tissue Pathology, Royal Prince Alfred Hospital, Camperdown, Sydney, New South Wales, Australia. · Pubmed 20564101
  • Royal Prince Alfred Hospital, Sydney, Camperdown, NSW, Australia. · Pubmed 20425144
2009
  • Royal Prince Alfred Hospital Discipline of Pathology, The University of Sydney, Camperdown Melanoma Institute Australia, New South Wales, Australia. · Pubmed 19851128
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 19658180
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, New South Wales, Australia. · Pubmed 19561232
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia. · Pubmed 19300224
2008
  • Royal Prince Alfred Hospital, Department of Anatomical Pathology, Camperdown, Sydney, NSW 2050, Australia. · Pubmed 18684064
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Camperdown, Sydney, Australia. · Pubmed 18854263
2013
  • *Department of Pathology †Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, USA ‡Melanoma Institute Australia, North Sydney §Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown ||Disciplines of Pathology ¶Surgery, Sydney Medical School, The University of Sydney, Camperdown NSW, Australia. · Pubmed 24018818
2012
  • Ludwig Institute for Cancer Research, Parkville, Vic., AustraliaDepartment of Surgery, Royal Melbourne Hospital, University of Melbourne, Vic., AustraliaJack Brockhoff Reconstructive Plastic Surgery Research Unit, Royal Melbourne Hospital and Department of Anatomy, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Vic., AustraliaTumour Angiogenesis Program, Peter MacCallum Cancer Centre, East Melbourne, Vic., AustraliaTissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, AustraliaThe University of Sydney, Sydney, NSW, AustraliaMelanoma Institute Australia, North Sydney, NSW, AustraliaThe Sir Peter MacCallum Department of Oncology, University of Melbourne, Vic., Australia. · Pubmed 22734806
2010
  • Sydney Melanoma Unit and Melanoma Institute Australia, Royal Prince Alfred and Mater Hospitals, Sydney, NSW, Australia. · Pubmed 19672660
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 20335819
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 19838163
2009
  • Melanoma Institute Australia incorporating the Sydney Melanoma Unit, Royal Prince Alfred and Mater Hospitals, Sydney, New South Wales, Australia. · Pubmed 19472395
2008
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 18697713
  • Sydney Melanoma Unit, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia. · Pubmed 18639451
  • Department of Radiation Oncology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 18823042
Probable:    Mater Hospital      
2012
  • Melanoma Institute Australia, Sydney, New South Wales, Australia. · Pubmed 22736239
2009
  • Royal Prince Alfred Hospital Discipline of Pathology, The University of Sydney, Camperdown Melanoma Institute Australia, New South Wales, Australia. · Pubmed 19851128
2013
  • *Department of Pathology †Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, USA ‡Melanoma Institute Australia, North Sydney §Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown ||Disciplines of Pathology ¶Surgery, Sydney Medical School, The University of Sydney, Camperdown NSW, Australia. · Pubmed 24018818
2012
  • Melanoma Institute Australia, Sydney, New South Wales, Australia. · Pubmed 23251089
  • Melanoma Institute Australia, 40 Rocklands Rd, North Sydney NSW 2060, Australia. · Pubmed 22711850
2010
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 21128774
  • Sydney Melanoma Unit and Melanoma Institute Australia, Royal Prince Alfred and Mater Hospitals, Sydney, NSW, Australia. · Pubmed 19672660
2009
  • Melanoma Institute Australia incorporating the Sydney Melanoma Unit, Royal Prince Alfred and Mater Hospitals, Sydney, New South Wales, Australia. · Pubmed 19472395
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 78 total) written by Rajmohan Murali about Melanoma:

  • A prediction tool incorporating the biomarker S-100B for patient selection for completion lymph node dissection in stage III melanoma. 2017
  • Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma. 2017
  • SF3B1 and BAP1 mutations in blue nevus-like melanoma. 2017
  • Activating CYSLTR2 and PLCB4 Mutations in Primary Leptomeningeal Melanocytic Tumors. 2017
  • Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy. 2016
  • Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system. 2016
  • Diagnosing a Primary Leptomeningeal Melanoma by Gene Mutation Signature. 2016
  • Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway. 2015
  • Analysis of SDHD promoter mutations in various types of melanoma. 2015
  • Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination. 2015
Show List of Full Article Records
Google Searches

Learn more about Rajmohan Murali using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Memorial Sloan-Kettering Cancer Center
Royal Prince Alfred Hospital
Mater Hospital
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Memorial Sloan-Kettering Cancer Center
2017
  • Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, The Netherlands. Electronic address: · Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, The Netherlands. Electronic address: · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, United States. Electronic address: · Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, The Netherlands. Electronic address: · Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, The Netherlands. Electronic address: · Department of Surgical Oncology, University of Leiden, Leiden University Medical Center, The Netherlands. Electronic address: · Pubmed 28797756
  • Department of Ophthalmology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany. · Institute of Pathology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany. · Department of Ophthalmology, University Hospital Tübingen, Tübingen, Germany. · Institute of Pathology, Ruhr University Bochum, Bochum, Germany. · Department of Dermatology, University Hospital Würzburg, Würzburg, Germany. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, United States. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany 8Dermatopathologie bei Mainz, Nieder-Olm, Germany. · Pubmed 28700778
  • Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany. · Dermatopathologie bei Mainz, Nieder-Olm, Germany. · Dermatopathology Friedrichshafen, Friedrichshafen, Germany. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · The University of Sydney, Camperdown, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Pathologie Salzburg, Salzburg, Austria. · Institute of Neuropathology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany. · Institute of Pathology, Ruhr University Bochum, Bochum, Germany. · Department of Dermatology, Medical University of Vienna, Vienna, Austria. · Department of Ophthalmology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany. · Department of Dermatology, University Hospital Würzburg, Würzburg, Germany. · Institute of Pathology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York NY, USA. · Pubmed 28409567
  • Institute of Pathology, Ruhr University Bochum, Bochum, Germany; Institute of Neuropathology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany. · Department of Neuropathology, Ruprecht-Karls-University Heidelberg, and Clinical Cooperation Unit Neuropathology, and DKTK, DKFZ, Heidelberg, Germany. · Institute of Neuropathology, University of Bonn Medical Center, Bonn, Germany; Division of Histopathology, Fondazione Policlinico Universitario "A.Gemelli", Università Cattolica del Sacro Cuore, Roma, Italy. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; The University of Sydney, Camperdown, NSW, Australia; Melanoma Institute Australia, North Sydney, NSW, Australia. · The University of Sydney, Camperdown, NSW, Australia; Department of Neuropathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Institute of Neuropathology, University of Bonn Medical Center, Bonn, Germany. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen, Germany; Dermatopathologie bei Mainz, Nieder-Olm, Germany. Electronic address: · Pubmed 28499758
2016
  • Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, United States; Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria. Electronic address: · Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria; Dermatopathologie Friedrichshafen, Friedrichshafen, Germany. · Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria. · Melanoma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, United States. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, United States; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, United States. · Pubmed 27020384
  • Institute of Neuropathology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Duisburg-Essen, Germany. · Institute of Neuropathology, University of Bonn Medical Center, Bonn, Germany. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) University of Duisburg-Essen, Duisburg-Essen, Germany. · Department of Ophthalmology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Duisburg-Essen, Germany. · Institute of Human Genetics, Medical University of Graz, Graz, Austria. · Tissue Pathology and Diagnostic Oncology, Camperdown, NSW, Australia. · The University of Sydney, Camperdown, NSW, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · Department of Neuropathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Pathology, Catholic University, Rome, Italy. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) University of Duisburg-Essen, Duisburg-Essen, Germany. · Pubmed 26744134
  • Institute of Neuropathology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Germany. · Department of Neurosurgery, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Germany. · Department of Radiology and Neuroradiology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Germany. · Department of Translational Skin Cancer Research, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Germany. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Germany. · Department of Ophthalmology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Germany. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Institute of Neuropathology, University of Bonn Medical Center, Bonn, Germany. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK), Germany. Electronic address: · Pubmed 27060446
2015
  • Department of Pathology, University of California, San Francisco, San Francisco, California, USA. · Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Department of Dermatology, University of California, San Francisco, San Francisco, California, USA. · Five3 Genomics, LLC, Santa Cruz, California, USA. · Samsung Advanced Institute of Technology, Seoul, Korea. · Department of Biomedical Engineering, Oregon Health and Sciences University, Portland, Oregon, USA. · Knight Cancer Institute, Oregon Health and Sciences University, Portland, Oregon, USA. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA. · Samsung Electronics Headquarters, Seoul, Korea. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Pubmed 26343386
  • Department of Ophthalmology, University Hospital Essen, University Duisburg-Essen, West German Cancer Center and the German Cancer Consortium (DKTK), Essen Germany. · Department of Dermatology, University Hospital Essen, University Duisburg-Essen, West German Cancer Center and the German Cancer Consortium (DKTK), Essen Germany. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York NY, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York NY, USA. · University Duisburg-Essen and the German Cancer Consortium (DKTK), Essen Germany. · Institute of Pathology, University Hospital Essen, University Duisburg-Essen, West German Cancer Center and the German Cancer Consortium (DKTK), Essen Germany. · Department of Human Genetics, University Hospital Essen, University Duisburg-Essen, West German Cancer Center and the German Cancer Consortium (DKTK), Essen Germany. · Pubmed 26327518
  • NantOmics LLC, Santa Cruz, CA 95060; · Samsung Advanced Institute of Technology, Suwon-si, Gyeonggi-do, 443-803, Korea; · Department of Statistics, University of California, Berkeley, CA 94720-3860; · Department of Biomedical Engineering, Knight Cancer Institute, Oregon Health Sciences University, Portland, OR 97239; · Melanoma Institute Australia, Crows Nest, NSW 1585, Australia; · Department of Medical and Molecular Genetics, Oregon Health & Science University, Portland, OR 97239-30; · Melanoma Institute Australia, Crows Nest, NSW 1585, Australia; Royal Prince Alfred Hospital, The University of Sydney, Camperdown, NSW 2050, Australia; · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095; · Department of Hematology and Oncology, University of California, San Francisco, CA 94143-1770; · Samsung Electronics, Inc. Seocho-gu, Seoul 137-857, Korea; · Department of Dermatology, University of California, San Francisco, CA 94115; · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Pathology, University of California, San Francisco, CA 94143-0511 · Pubmed 26286987
  • Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) (KGG, DS) · Department of Pathology (RM) and Marie-Josée and Henry R. Kravis Center for Molecular Oncology (RM), Memorial Sloan Kettering Cancer Center, New York, NY · Integriertes Forschungs- und Behandlungszentrum (IFB) Sepsis und Sepsisfolgen, Center for Sepsis Control and Care (CSCC) University Hospital Jena, Jena Germany (AS). · Pubmed 25755156
2014
  • Affiliations of authors: Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany (KGG, DS) · Royal Prince Alfred Hospital, Camperdown, NSW, Australia (RAS) · University of Sydney, Camperdown, NSW, Australia (RAS, JFT) · Melanoma Institute Australia, North Sydney, NSW, Australia (RAS, JFT) · Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA (KTF) · Department of Pathology, and Center for Molecular Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY (RM). · Pubmed 24511108
  • Department of Dermatology,University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen and the German Cancer Consortium (KGG, BS, EL, TS, IM, MS, AS, UH, LZ, DS), Germany · Department of Pathology and Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY (RM) · CIBER Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain (JAPB, MP, CC, CB, JM, SP) · Department of Dermatology, Hospital Clinic Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain (CC, JM, SP) · Biochemistry and Molecular Genetics Department, Hospital Clinic Barcelona, IDIBAPS, Barcelona, Spain (CB) · Integriertes Forschungs- und Behandlungszentrum (IFB) Sepsis und Sepsisfolgen Center for Sepsis Control and Care (CSCC) University Hospital Jena, Jena, Germany (AS). · Pubmed 25217772
  • Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California (D.M.M., J.L.H., D.S.B.H.) · Department of Tissue Oncology and Diagnostic Pathology (R.A.S., M.E.B., J.F.T.) and Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia (J.F.T.) · Sydney Medical School, The University of Sydney, Sydney, Australia (R.A.S., J.S.W., M.E.B., J.F.T.) · Melanoma Institute Australia, Sydney, Australia (R.A.S., J.S.W.) · Cellular and Molecular Biology Laboratory, Institute of Histology and Embryology, Mendoza, Argentina (M.R.) · Tumor Biology Laboratory, Institute of Medicine and Experimental Biology of Cuyo, Mendoza, Argentina (L.M.V.-R.) · Department of Pathology (R.M.), Center for Molecular Oncology (R.M.), and Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York (R.M.) · Division of Surgical Oncology, John Wayne Cancer Institute, Santa Monica, California (D.L.M.) · Brain Tumor Center, Saint John's Health Center, Santa Monica, California (G.B., D.F.K.). · Pubmed 24968695
  • Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, 415 E 68th Street, New York, New York 10065, USA. · Department of Dermatology and Venereology, Medical University of Graz, Auenbruggerplatz 8, 8036 Graz, Austria. · Foundation Medicine, 1 Kendall Sq B6501, Cambridge, Massachusetts 02139, USA. · Departments of Dermatology and Pathology, UCSF Cardiovascular Research Institute, 555 Mission Bay Blvd. South, Room 252K, Box 3118, San Francisco, California 94158-9001, USA. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue New York, New York 10065, USA. · Dermatopathologie Friedrichshafen, Siemensstraße 6/1, 88048 Friedrichshafen, Germany. · Pubmed 24445538
  • Erasmus University Medical Center, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. · Melanoma Institute Australia, Sydney, Australia. · Memorial Sloan Kettering Cancer Center, New York City, NY, USA. · Institut de Cancerologie Gustav Roussy, Villejuif, Paris-Sud, France. Electronic address: · Pubmed 24074765
  • Department of Dermatology, University of Duisburg-Essen, Essen, Germany. · Institute of Pathology and Neuropathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. · 1] The University of Sydney, Camperdown, NSW, Australia [2] Melanoma Institute Australia, North Sydney, NSW, Australia. · Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · 1] The University of Sydney, Camperdown, NSW, Australia [2] Melanoma Institute Australia, North Sydney, NSW, Australia [3] Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · 1] Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA [2] Department of Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 23887304
2013
  • Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. · Pubmed 23277170
  • Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. Electronic address: · Pubmed 23890716
2012
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 22350600
  • Melanoma Institute Australia, Sydney, New South Wales, Australia. · Pubmed 22736239
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, and Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 22271204
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 21975320
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 21913010
2011
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 21438911
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 21412144
2013
  • *Department of Pathology, University of Virginia School of Medicine, Charlottesville VA †Department of Pathology ‡Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, United States. · Pubmed 24247622
  • *Department of Pathology †Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, USA ‡Melanoma Institute Australia, North Sydney §Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown ||Disciplines of Pathology ¶Surgery, Sydney Medical School, The University of Sydney, Camperdown NSW, Australia. · Pubmed 24018818
2012
  • Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Box 20, New York, NY 10065, USA. · Pubmed 23032617
2009
  • Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 19609204
Royal Prince Alfred Hospital
2012
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 22350600
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, and Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 22271204
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 21975320
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 21913010
2011
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 21438911
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 21412144
2010
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 20106719
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 20823419
  • Diagnostic Oncology and Tissue Pathology, Royal Prince Alfred Hospital, Camperdown, Sydney, New South Wales, Australia. · Pubmed 20564101
  • Royal Prince Alfred Hospital, Sydney, Camperdown, NSW, Australia. · Pubmed 20425144
2009
  • Royal Prince Alfred Hospital Discipline of Pathology, The University of Sydney, Camperdown Melanoma Institute Australia, New South Wales, Australia. · Pubmed 19851128
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 19658180
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, New South Wales, Australia. · Pubmed 19561232
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia. · Pubmed 19300224
2008
  • Royal Prince Alfred Hospital, Department of Anatomical Pathology, Camperdown, Sydney, NSW 2050, Australia. · Pubmed 18684064
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Camperdown, Sydney, Australia. · Pubmed 18854263
2013
  • *Department of Pathology †Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, USA ‡Melanoma Institute Australia, North Sydney §Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown ||Disciplines of Pathology ¶Surgery, Sydney Medical School, The University of Sydney, Camperdown NSW, Australia. · Pubmed 24018818
2012
  • Ludwig Institute for Cancer Research, Parkville, Vic., AustraliaDepartment of Surgery, Royal Melbourne Hospital, University of Melbourne, Vic., AustraliaJack Brockhoff Reconstructive Plastic Surgery Research Unit, Royal Melbourne Hospital and Department of Anatomy, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Vic., AustraliaTumour Angiogenesis Program, Peter MacCallum Cancer Centre, East Melbourne, Vic., AustraliaTissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, AustraliaThe University of Sydney, Sydney, NSW, AustraliaMelanoma Institute Australia, North Sydney, NSW, AustraliaThe Sir Peter MacCallum Department of Oncology, University of Melbourne, Vic., Australia. · Pubmed 22734806
2010
  • Sydney Melanoma Unit and Melanoma Institute Australia, Royal Prince Alfred and Mater Hospitals, Sydney, NSW, Australia. · Pubmed 19672660
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 20335819
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 19838163
2009
  • Melanoma Institute Australia incorporating the Sydney Melanoma Unit, Royal Prince Alfred and Mater Hospitals, Sydney, New South Wales, Australia. · Pubmed 19472395
2008
  • Department of Anatomical Pathology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 18697713
  • Sydney Melanoma Unit, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia. · Pubmed 18639451
  • Department of Radiation Oncology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 18823042
Mater Hospital
2012
  • Melanoma Institute Australia, Sydney, New South Wales, Australia. · Pubmed 22736239
2009
  • Royal Prince Alfred Hospital Discipline of Pathology, The University of Sydney, Camperdown Melanoma Institute Australia, New South Wales, Australia. · Pubmed 19851128
2013
  • *Department of Pathology †Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, USA ‡Melanoma Institute Australia, North Sydney §Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown ||Disciplines of Pathology ¶Surgery, Sydney Medical School, The University of Sydney, Camperdown NSW, Australia. · Pubmed 24018818
2012
  • Melanoma Institute Australia, Sydney, New South Wales, Australia. · Pubmed 23251089
  • Melanoma Institute Australia, 40 Rocklands Rd, North Sydney NSW 2060, Australia. · Pubmed 22711850
2010
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 21128774
  • Sydney Melanoma Unit and Melanoma Institute Australia, Royal Prince Alfred and Mater Hospitals, Sydney, NSW, Australia. · Pubmed 19672660
2009
  • Melanoma Institute Australia incorporating the Sydney Melanoma Unit, Royal Prince Alfred and Mater Hospitals, Sydney, New South Wales, Australia. · Pubmed 19472395
University of Sydney
2012
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, and Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 22271204
2009
  • Royal Prince Alfred Hospital Discipline of Pathology, The University of Sydney, Camperdown Melanoma Institute Australia, New South Wales, Australia. · Pubmed 19851128
2013
  • *Department of Pathology †Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, USA ‡Melanoma Institute Australia, North Sydney §Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown ||Disciplines of Pathology ¶Surgery, Sydney Medical School, The University of Sydney, Camperdown NSW, Australia. · Pubmed 24018818
2012
  • Ludwig Institute for Cancer Research, Parkville, Vic., AustraliaDepartment of Surgery, Royal Melbourne Hospital, University of Melbourne, Vic., AustraliaJack Brockhoff Reconstructive Plastic Surgery Research Unit, Royal Melbourne Hospital and Department of Anatomy, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Vic., AustraliaTumour Angiogenesis Program, Peter MacCallum Cancer Centre, East Melbourne, Vic., AustraliaTissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, AustraliaThe University of Sydney, Sydney, NSW, AustraliaMelanoma Institute Australia, North Sydney, NSW, AustraliaThe Sir Peter MacCallum Department of Oncology, University of Melbourne, Vic., Australia. · Pubmed 22734806
2010
  • Sydney Melanoma Unit and Melanoma Institute Australia, Royal Prince Alfred and Mater Hospitals, Sydney, NSW, Australia. · Pubmed 19672660
  • Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 20335819
17 Other Locations Show
Yearly article counts 004347101451687
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.